Form 4: Vericel Director Sells Shares Under 10b5-1 Plan

Vericel Corp Director Paul K Wotton sold 5,000 shares of common stock in two transactions totaling approximately $189,500 under a pre-arranged 10b5-1 plan.

Summary

• Paul K Wotton, a Director of Vericel Corp (VCEL), reported the sale of 5,000 shares of common stock.
• The sales occurred in two separate transactions: 2,500 shares on December 2, 2025, and another 2,500 shares on December 3, 2025.
• The shares were sold at an average price of $37.97 per share on December 2, 2025, and $37.83 per share on December 3, 2025.
• The total proceeds from these sales amounted to approximately $189,500.
• Following these transactions, Paul K Wotton beneficially owns 25,602 shares of Vericel Corp common stock.
• The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: A director's pre-planned sale of shares, as disclosed in a Form 4, is a routine disclosure and does not inherently indicate positive or negative sentiment about the company's future, especially when executed under a 10b5-1 plan.

Future Outlook

N/A

Industry Context

N/A

Stakeholder Impact

• Shareholders may note a director's sale of shares, which could be interpreted in various ways, though the 10b5-1 plan suggests a pre-scheduled event rather than a reaction to new, undisclosed information.

Key Dates

Recommendation

The Form 4 filing reports a pre-planned sale of shares by a director under a Rule 10b5-1 plan. Such routine insider transactions, particularly when pre-scheduled, generally do not provide sufficient new information to alter an investment recommendation for the stock. Investors should consider the company's broader financial performance and strategic outlook.

Keywords

Vericel Corp, VCEL, Insider Trading, Form 4, Stock Sale, Director Transaction, Paul K Wotton, 10b5-1 plan